Literature DB >> 1831564

Thymocyte expression of RAG-1 and RAG-2: termination by T cell receptor cross-linking.

L A Turka1, D G Schatz, M A Oettinger, J J Chun, C Gorka, K Lee, W T McCormack, C B Thompson.   

Abstract

The expression of the V(D)J [variable (diversity) joining elements] recombination activating genes, RAG-1 and RAG-2, has been examined during T cell development in the thymus. In situ hybridization to intact thymus and RNA blot analysis of isolated thymic subpopulations separated on the basis of T cell receptor (TCR) expression demonstrated that both TCR- and TCR+ cortical thymocytes express RAG-1 and RAG-2 messenger RNA's. Within the TCR+ population, RAG expression was observed in immature CD4+CD8+ (double positive) cells, but not in the more mature CD4+CD8- or CD4-CD8+ (single positive) subpopulations. Thus, although cortical thymocytes that bear TCR on their surface continue to express RAG-1 and RAG-2, it appears that the expression of both genes is normally terminated during subsequent thymic maturation. Since thymocyte maturation in vivo is thought to be regulated through the interaction of the TCR complex with self major histocompatibility complex (MHC) antigens, these data suggest that signals transduced by the TCR complex might result in the termination of RAG expression. Consistent with this hypothesis, thymocyte TCR cross-linking in vitro led to rapid termination of RAG-1 and RAG-2 expression, whereas cross-linking of other T cell surface antigens such as CD4, CD8, or HLA class I had no effect.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831564     DOI: 10.1126/science.1831564

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  69 in total

Review 1.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  RAG2 is regulated differentially in B and T cells by elements 5' of the promoter.

Authors:  R J Monroe; F Chen; R Ferrini; L Davidson; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

3.  Response to RAG-mediated VDJ cleavage by NBS1 and gamma-H2AX.

Authors:  H T Chen; A Bhandoola; M J Difilippantonio; J Zhu; M J Brown; X Tai; E P Rogakou; T M Brotz; W M Bonner; T Ried; A Nussenzweig
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

Review 4.  Disorderly conduct in gammadelta versus alphabeta T cell lineage commitment.

Authors:  Kavitha Narayan; Joonsoo Kang
Journal:  Semin Immunol       Date:  2010-05-06       Impact factor: 11.130

Review 5.  Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.

Authors:  Lie Wang; Yumei Xiong; Rémy Bosselut
Journal:  Semin Immunol       Date:  2010-10       Impact factor: 11.130

6.  c-Myb binds to a sequence in the proximal region of the RAG-2 promoter and is essential for promoter activity in T-lineage cells.

Authors:  Q F Wang; J Lauring; M S Schlissel
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

7.  Defective signal transduction by the CD2 molecule in immature T-cell receptor/CD3- thymocytes.

Authors:  L A Turka; M C Fletcher; N Craighead; C B Thompson; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

8.  Revision of T cell receptor {alpha} chain genes is required for normal T lymphocyte development.

Authors:  Ching-Yu Huang; Barry P Sleckman; Osami Kanagawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

9.  Role for rearranged variable gene segments in directing secondary T cell receptor alpha recombination.

Authors:  Abbas Hawwari; Michael S Krangel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

10.  Induction of recombinase activity in peripheral T cells in multiple sclerosis.

Authors:  E M Kuklina; I V Nekrasova; O L Schuklina; T V Baydina; I Yu Danchenko
Journal:  Dokl Biol Sci       Date:  2014-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.